今开:0.0 | 昨收:1.07 |
最高:0.0 | 最低:0.0 |
涨停价:0.0 | 跌停价:0.0 |
总市值:6.5082187E7 |
看看eh3溪水长流2021-09-08 19:09
$Surface Oncology(SURF)$ 先天性与适应性两大免疫系统结合治疗是免疫疗法的关键。国内cd47大量与pd1联合,部分实体瘤数据不错。看好这个趋势查看全文
逍遥谷-百奥生2021-09-04 03:19
Surf $Surface Oncology(SURF)$ 建半仓,6.25,建了几手观察仓$Medicenna(MDNA)$ 2.32, 潜力巨大,风险巨大的一支股票。查看全文
牛唐2021-08-23 21:50
与被收购的TRIL一样,CD47概念股还有:$ALX Oncology(ALXO)$ 、$Shattuck(STTK)$ 、$Surface Oncology(SURF)$查看全文
一个劳苦大众2021-06-04 20:57
$Surface Oncology(SURF)$ 2021 年 6 月 4 日,Surface Oncology, Inc.(“公司”)公布了正在进行的 SRF388 和 SRF617 第一阶段研究的新数据。初步的 SRF388 结果表明单药在大量预处理的人群中具有有希望的活性,包括证实的部分反应表明鳞状细胞非小细胞肺癌 (“NSCLC”)患者的肿瘤缩小 66% 和症...查看全文
智通财经APP获悉,据媒体消息,专攻免疫疗法的Surface Oncology(SURF.US)公司收到了葛兰素史克(GSK.US)的收购意向。 报道称,除葛兰素史克之外,Surface Oncology还在寻找其它任何可能的收购者。 此前,百时美施贵宝(BMY.US)在同意收... 网页链接
$Surface Oncology(SURF)$ 15-12G Securities registration termination [Section 12(g)] Accession Number: 0001193125-23-236303 Act: 34 Size: 12 KB 网页链接
$Surface Oncology(SURF)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-002629 Act: 33 Size: 1 KB 网页链接
$Surface Oncology(SURF)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-002628 Act: 33 Size: 1 KB 网页链接
$Surface Oncology(SURF)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-23-231522 Act: 33 Size: 21 KB 网页链接
$Surface Oncology(SURF)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-231530 Act: 33 Size: 23 KB 网页链接
$Surface Oncology(SURF)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-231534 Act: 33 Size: 23 KB 网页链接
$Surface Oncology(SURF)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-231535 Act: 33 Size: 23 KB 网页链接
$Surface Oncology(SURF)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-231539 Act: 33 Size: 23 KB 网页链接
$Surface Oncology(SURF)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-231542 Act: 33 Size: 23 KB 网页链接
$Surface Oncology(SURF)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-231544 Act: 33 Size: 23 KB 网页链接